102 related articles for article (PubMed ID: 604104)
1. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Kasel JA; Laver WG
Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the immune response to influenza virus subunit vaccines.
Webster RG; Glezen WP; Hannoun C; Laver WG
J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials with a new influenza subunit vaccine in adults and children.
Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
[TBL] [Abstract][Full Text] [Related]
4. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
[TBL] [Abstract][Full Text] [Related]
5. IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.
Boyer KM; Cherry JD; Noble GR
Dev Biol Stand; 1977 Jun 1-3; 39():303-8. PubMed ID: 604113
[TBL] [Abstract][Full Text] [Related]
6. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
[TBL] [Abstract][Full Text] [Related]
7. Serological responses to whole and split A/New Jersey vaccines in humans and mice following priming infection with influenza A viruses.
Ennis FA; Wise TG; McLaren C; Verbonitz MW
Dev Biol Stand; 1977 Jun 1-3; 39():261-6. PubMed ID: 604108
[TBL] [Abstract][Full Text] [Related]
8. Human responses to purified surface antigen invluenza vaccine (Fluvirin).
Stones PB; Furminger IG; Kerr J
Dev Biol Stand; 1977 Jun 1-3; 39():239-42. PubMed ID: 604103
[TBL] [Abstract][Full Text] [Related]
9. Persistence of influenza A/New Jersey/76 (Hsw1N1) antibody one year after vaccination.
Noble GR; Kaye HS; O'Brien RJ; Kendal AP; Bregman DJ; Wright PF; Amler RW; Dowdle WR
Dev Biol Stand; 1977 Jun 1-3; 39():253-60. PubMed ID: 604107
[TBL] [Abstract][Full Text] [Related]
10. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
Muhamed G; Greenbaum E; Zakay-Rones Z
Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
[TBL] [Abstract][Full Text] [Related]
11. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
Brett IC; Johansson BE
Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
Beutner KR; Rizzone C; DeMello S; Ogra PL
Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.
Ben-Yehuda A; Joseph A; Zeira E; Even-Chen S; Louria-Hayon I; Babai I; Zakay-Rones Z; Greenbaum E; Barenholz Y; Kedar E
J Med Virol; 2003 Apr; 69(4):560-7. PubMed ID: 12601765
[TBL] [Abstract][Full Text] [Related]
14. Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen).
Sarateanu D; Ehrengut W; Pressler K
Dev Biol Stand; 1977 Jun 1-3; 39():235-8. PubMed ID: 604102
[TBL] [Abstract][Full Text] [Related]
15. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
16. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
Johansson BE; Moran TM; Bona CA; Kilbourne ED
J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
[TBL] [Abstract][Full Text] [Related]
17. Further researches on live influenza virus vaccines.
De Barbieri A; Crovari P; Cuneo-Crovari P; Giacometti G
Dev Biol Stand; 1977 Jun 1-3; 39():73-6. PubMed ID: 604136
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to anti-A/New Jersey/76 vaccines.
Hannoun C; Barme M; Sérié C; Beck H; Aquino J; Thibon M
Dev Biol Stand; 1977 Jun 1-3; 39():249-52. PubMed ID: 604105
[TBL] [Abstract][Full Text] [Related]
19. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
20. The antibody response and immunity to challenge infection induced by whole, inactivated and tween-ether split influenza vaccines.
Potter CW; Jennings R; Clark A
Dev Biol Stand; 1977 Jun 1-3; 39():323-8. PubMed ID: 604115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
